Evidence map›Paper›PMID 31598849›Full record

ArticleEndocrine2020

TLR4 knockout can improve dysfunction of β-cell by rebalancing proteomics disorders in pancreas of obese rats.

Sunjie Yan, Zhen Jiang, Ling Cheng, Youfen Lin, Beibei Fan, Liufen Luo, Yuanli Yan, Liyong Yang, Ximei Shen

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Experimental and therapeutic medicine · 2020
    Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Sunjie YanFrom Endocrinology Department, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, Fujian, China.
Zhen JiangFrom Endocrinology Department, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, Fujian, China.
Ling ChengFrom Endocrinology Department, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, Fujian, China.
Youfen LinFrom Endocrinology Department, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, Fujian, China.
Beibei FanFrom Endocrinology Department, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, Fujian, China.
Liufen LuoFrom Endocrinology Department, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, Fujian, China.
Yuanli YanFrom Endocrinology Department, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, Fujian, China.
Liyong YangFrom Endocrinology Department, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, Fujian, China.
Ximei ShenFrom Endocrinology Department, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, Fujian, China. 641498885@qq.com.ORCID 0000-0003-0598-366X
Fujian Medical University · CN

Funding

Science and technology innovation joint fund project Fujian Province 2016Y9102
6 · The paper itself

Abstract

purposeStudies showed that TLR4 knockout (TLR4

methodsPA-induced lipotoxicity β-cells, SD and TLR4

resultsTLR4

conclusionsOur study confirmed that TLR4

Indexed as

ProteomicsToll-Like Receptor 4AnimalsGene Knockout TechniquesInsulinObesityPancreasPhosphatidylinositol 3-KinasesRatsInsulinPhosphatidylinositol 3-KinasesTlr4 protein, ratToll-Like Receptor 4Ass1iTRAQMetabolic inflammationTLR4β-cells; Obesity

Identifiers

PMID31598849
OpenAlexW2979504520

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.